Back to results
US 7,396,823 B2Granted
Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
OwnerRahul K. Nath, Rajinder Beriinventors
Life of this patent
Estimating the term…
Abstract
The invention provides antisense DNA oligonucleotides which are effective in inhibiting the expression of a wild type COL1A1 gene, wherein said oligonucleotides are used in inhalation therapy to treat various lung diseases.
Claims2
A method of treating a collagen disorder in a patient suffering from, a lung disease relating to the collagen disorder, which comprises administering inhalation therapy to the patient using a therapeutically effective amount of an antisense DNA oligonucleotide having SEQ ID NO:14.
Dependencies are inferred from the claim text.